PHARMALEX
LIVE

Serial Number

98015957

Owner

PharmaLex GmbH

Attorney

Anita B. Polott

Filing Date

May 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PHARMALEX Trademark

Serial Number: 98015957 • Registration: 7675015

PHARMALEX is a trademark filed by PharmaLex GmbH on May 26, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PharmaLex GmbH (10 trademarks)

Bahnstrasse 42-46

Entity Type: 99

Trademark Details

Filing Date

May 26, 2023

Registration Date

February 4, 2025

Published for Opposition

December 17, 2024

Goods & Services

Advertising and marketing; management of business for others; business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business development services and advice in the field of drug distribution in retail and wholesale stores for advertising purposes; providing outsourced office functions services for drug approval, manufacturing, distribution, supply chain security and safety monitoring; assistance and consultancy in the field of distributing medicines for advertising purposes via retail stores and wholesale stores; business consultancy services in the fields of controlling and managing business information and implementing and managing databases; regulatory submission management, namely, assisting others in preparing and filing applications, documents, reports and records for new drugs required for drug approval by governmental regulatory authorities; advisory services in the field of regulatory submission management to assist companies with applications for pharmaceuticals, biopharmaceuticals, and medical devices; business advice and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing marketing authorization applications with governmental regulatory bodies following approval of new drugs; consultancy relating to conducting quality assurance for manufacturing for pharmaceutical companies

Regulatory compliance auditing; regulatory compliance consulting in the field of pharmaceuticals, medical devices, and biopharmaceuticals; consultancy services in the fields of regulatory compliance and oversight in the field of pharmaceuticals, medical devices, and biopharmaceuticals; advisory services relating to regulatory compliance auditing; regulatory compliance consultancy in the field of prescription drug sampling

Medical and veterinary services; advice in the field of preparation of prescriptions in pharmacies; providing medical advice regarding the appropriate medical information that should appear on labels of pharmaceutical products and biopharmaceutical products; providing information relating to the preparation and dispensing of medications; provision of information in the field of medicine; consultancy and information services provided via the Internet relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the dispensing of biopharmaceutical products; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations relating to the treatment of persons; medical analysis services relating to the treatment of persons; medical services; medical screening; medical diagnostic monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses; medical and medical diagnostic services and medical advice in the field of drug safety for the diagnosis and treatment of persons; providing information in the field of pharmacovigilance and adverse event reporting for the diagnosis and treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of persons

Scientific and technological services, namely, research and design in the field of pharmaceuticals, medical devices, and biopharmaceuticals; scientific, medical and pharmaceutical research and development services; industrial analysis and research services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific, medical, biotechnological, and pharmaceutical research services; biological research and analysis services for scientific and technological purposes; technological research services relating to pharmaceuticals, biopharmaceuticals, and medical devices; biological research; clinical research in the field of pharmaceuticals, medical devices, and biopharmaceuticals; providing medical research and scientific research information; provision of scientific information in the nature of scientific surveys; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics; computer software development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents; database services, namely, electronic storage of data in computer databases; conversion of data or documents from physical to electronic media; testing, inspection or research of pharmaceuticals and medicines; design, engineering, research, development and testing services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; research in the field of gene therapy; consultancy relating to quality management services, namely, quality assurance and quality control in the field of pharmaceuticals, pharmaceutical manufacturing, medical devices, and biopharmaceuticals; research services relating to scientific work; preparation of scientific research analyses and evaluations relating to pharmaceuticals, medical devices, and biopharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to scientific laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; information technology consultancy services relating to computer software design for the pharmaceutical and healthcare industries; scientific evaluation of the drugs of others to determine drug efficacy; research and development services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design for others; analysis and evaluation of product development for others; quality control testing for others; materials testing and evaluation; product safety testing; quality control and evaluation of goods of others to determine conformity with certification standards; quality testing of products for certification purposes; consulting and advice on drug safety and monitoring for product research and development purposes; consultancy services for others in the field of design, planning, implementation and project management of clinical trials, scientific pharmacovigilance research, and pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing of materials and pharmacogenetics; providing online nondownloadable software for collecting data related to clinical trials; providing online non-downloadable automation software for collecting data related to clinical trials; provision of pharmaceutical information regarding pharmaceutical research and development; consultancy and information services provided via the Internet relating to the research and development of pharmaceutical products; pharmaceutical drug development services in the field of drug safety

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2024 CRFA
ASSIGNED TO LIE
Nov 7, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 20, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 20, 2024 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2023 NWOS
NEW APPLICATION ENTERED
May 30, 2023 NWAP